Salehpour S, Masoodzadeh A, Khalilian A R, Setareh J. EEG Data as a Predictor Index of Efficacy of Clozapine Therapy in Resistant Schizophrenia. J Mazandaran Univ Med Sci 2013; 23 (105) :2-7
URL:
http://jmums.mazums.ac.ir/article-1-3002-en.html
Abstract: (7753 Views)
Background and purpose: EEG is used as a diagnostic tool in the diagnosis and prognosis of
disease spread. Among the psychiatric illnesses that can utilize EEG to measure response to treatment,
schizophrenia can be noted. Many investigations on the application of data EEG as a predictor of
treatment response in patients with schizophrenia refractory to clozapine has been done in order to resolve
contradictions and the limitations of previous studies. We studied the response to treatment with
clozapine, with the PANSS greater number of samples making them prior studies have examined.
Material & methods: In a cross-sectional study, 70 patients with schizophrenia resistant to
treatment with candidates receiving clozapine were selected from those EEG and PANSS baseline was
patient during twelve weeks of treatment with clozapine were again patients PANSS was used and EEG
raw patients with a good response to treatment and disease with poor response to treatment were
compared with each other. After data collection, descriptive statistics software SPSS17 square test was
used for the analysis of EEG data from a linear regression to examine the relationship between the
indicators of response to clozapine treatment.
Results: The results showed that there is coherence of EEG and the treatment response to
clozapine significant correlation was (P= 0.00). The results showed that there is presence of asymmetry in
EEG and the treatment response to clozapine significant correlation was (P= 0.8).
Conclusion: The EEG abnormalities include coherence of EEG in predicting response to
treatment in patients with treatment-resistant schizophrenia to clozapine which is effective.